[Cryoglobulinemia].
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000936:Antigen-Antibody Complex; D001809:Blood Viscosity; D003095:Collagen Diseases / Q000097:blood; D003165:Complement System Proteins; D003450:Cryoglobulins; D003587:Cytomegalovirus; D004247:DNA / Q000097:blood; D006801:Humans; D007105:Immune Complex Diseases / Q000097:blood; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007244:Infectious Mononucleosis / Q000150:complications; D008623:Mercaptoethanol / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D011693:Purpura / Q000209:etiology; D011817:Rabbits; D011928:Raynaud Disease / Q000209:etiology; D012217:Rheumatoid Factor; D014612:Vaccines / Q000009:adverse effects
D000477:Alkylating Agents; D000936:Antigen-Antibody Complex; D003450:Cryoglobulins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D014612:Vaccines; D008623:Mercaptoethanol; D003165:Complement System Proteins; D004247:DNA; D012217:Rheumatoid Factor; D015122:Mercaptopurine; D010396:Penicillamine; D008727:Methotrexate